Genus plc (LON:GNS) has received an average rating of “Hold” from the five brokerages that are covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is GBX 1,950 ($25.22).

GNS has been the subject of several analyst reports. Peel Hunt restated a “buy” rating on shares of Genus plc in a report on Thursday, June 1st. Liberum Capital reaffirmed a “buy” rating on shares of Genus plc in a research report on Monday, June 19th.

Genus plc (GNS) remained flat at GBX 1835.00 during mid-day trading on Tuesday. The company’s stock had a trading volume of 23,084 shares. The firm has a 50 day moving average price of GBX 1,759.11 and a 200 day moving average price of GBX 1,792.24. Genus plc has a 12 month low of GBX 1,652.00 and a 12 month high of GBX 2,113.00. The company’s market cap is GBX 1.12 billion.

TRADEMARK VIOLATION WARNING: “Genus plc (GNS) Given Average Recommendation of “Hold” by Analysts” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at

Genus plc Company Profile

Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.

Analyst Recommendations for Genus plc (LON:GNS)

Receive News & Stock Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related stocks with our FREE daily email newsletter.